Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients

NCT00631059 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT00631059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00631059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients
Lead sponsor
University of California, Irvine
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2008
Completion date
June 30, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia